We thus assume that differential OPN proteolysis, affecting assay sensitivity and variability, might account for the observed lack of statistical significance at baseline and 4 months, although a slight trend to higher OPN levels in patients with IPF was indeed visible at 4 months.
← all excerpts
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.
1
—
—